Program 2014

Monday, September 15, 2014
6:30 – 8:30 PM Speaker’s Dinner, Invitation only  

Tuesday, September 16, 2014
8:45 AM Welcome Remarks
9:00 – 10:10 AM

East Asia: Assessing the Opportunities & Risks in the Major Healthcare Markets

Moderator:

  • Glen Giovannetti, Global Biotechnology Leader, EY

Panelists:

  • May-Kin Ho, PhD,Advisory Director, Goldman Sachs & Co.
  • W. Vincent Xiang, PhD. MBA, Managing Director, Vice President, International Investments and Business Development, Humanwell Healthcare Group
  • Harold R. Werner, Co-Founder, HealthCare Ventures
10:15– 11:10 AM

Comparing Regulatory Regimes: Understanding the Differences, Avoiding Missteps and Getting Your Drug Through the Process

Moderator:

  • Scott Siegel PhD, Founder, Milestone Life Sciences, LLC

Panelists:

  • John C. Balzano, JD, Special Counsel, Covington & Burling LLP
  • Jurij Petrin, MD, President & CEO, Pharmaceutical Regulatory Services, Inc.
  • Mark Tang, PhD, MBA, Founder and Chairman, GCA Therapeutics, Ltd.
11:15 – 12:10 PM

Conducting Clinical Trials in East Asia: The Benefits and Operational Realities You Need to Know

Panelists:

  • Pey Ni Chan, Managing Director, CMIC Asia-Pacific, Pte. Ltd.
  • Keiko Oishi, Senior Managing Director, CMIC Co., Ltd.
  • Peony Yu, MD, Vice President, Clinical Development, FibroGen, Inc.
12:15 – 1:40 PM Lunch with the Experts

Fireside Chat: Minimizing Risk to Maximize Opportunity

  • Joshua Berlin, Executive Director & Editor of New Ventures, BioCentury Publications Inc.
  • Alan Seem, JD, Partner, Sherman & Sterling

 
1:45 – 2:40 PM A Focus on China: Big Opportunities, Big Challenges and Navigating Your Way
Moderator:

  • Charles Hsu, PhD, Managing Partner, Crosswave Management & Senior Advisor, Mustang Ventures

Panelists:

  • John Gill, Founder and Former CEO, Tetralogic Pharmaceuticals
  • Andrew Pecora, MD, Chairman, TetraLogic Pharmaceuticals Corporation and Chief Visionary Officer, NeoStem, Inc.
  • Joseph Vacca, PhD, Senior Vice President, Early Success Sharing Partnerships, WuXi AppTec
  • Alan Yan, Co-Founder, President & CEO, Beijing SynerCare Pharma Tech Co., Ltd.
  • Debra Yu, MD, Managing Director, Labrador Advisors
2:45 – 3:40 PM East Asian Biotech Venture Funds: What Are They Investing in and Where?

Moderator:

  • Kimberly Ha, Senior Director, FTI Consulting

Panelists:

  • Les Funtleyder, Director of Strategic Investments, OPKO Health
  • Wei Li, PhD, Executive Partner-China, Fidelity Biosciences
  • Anjiang (Vincent) Liu, Managing Director, International Investment & Chief Representative, NY Office, FosunPharma Group
  • Tomomi Okamoto, Partner, Sophia Hill Venture Partners
  • Anthony (Tony) Sun, MD, Partner, Aisling Capital
3:45 – 5:00 PM Biopharmaceutical Innovation in East Asia: What are the Drivers and Impact and Where is it Going?

Moderator:

  • Joshua Berlin, Executive Director & Editor of New Ventures, BioCentury Publications Inc.

Panelists:

  • Ben Bonifant, Founder & Partner, Triangle Insights Group
  • Peter B. Corr, Co-Founder & Managing General Partner, Auven Therapeutics
  • James Huang, Managing Partner, Kleiner Perkins Caufield & Byers China
  • Kiyoshi Kurokawa, Professor, National Graduate Institute for Policy Studies & Science Advisor, National Diet, Japan
5:00 – 6:30 PM Networking Reception


Wednesday, September 17, 2014
8:45 – 9:55 AM

Expanding into East Asia: Considerations for All Management Teams

Moderator:

  • Wei Zhang, PhD, Head, Corporate Development, GoodStart Genetics, Inc.

Panelists:

  • Helen Chen, Head, China Life Sciences
  • Martyn D. Greenacre, MBA, Former Chairman, BMP Sunstone
  • Alex Waldron, Vice President Global Commercial Operations, EPIRUS Biopharmaceuticals, Inc.
  • Gunther Winkler, PhD, Founder & CEO, BioMetheus LLC
  • Cissy S. Young, Ph.D. MBA, Executive Director, Life Sciences Practice, Russell Reynolds Associates
  
10:00 11:10 AM Getting the Deal Done: The Due Diligence of Deal Making in Asia
Moderator:

  • Jack M. Anthony, Founder, BioMentorz

Panelists:

  • Jay N. Fastow, JD, Partner, Ballard Spahr
  • James Foley, Managing Director, Aqua Partners
  • Martina Molsbergen, CEO, C14 Consulting Group
  • Richard L. Sherman, JD, Senior Vice President, Strategic Transactions & General Counsel, Tetralogic Pharmaceuticals
  • Wenyong Wang, PhD, Managing Director, Merchant & Investment Banking, Burrill Securities
  
11:15 –12:10 PM Intellectual Property From the Trenches: Exploiting Your Discoveries and Protecting Them at the Same Time

Moderator:

  • Grace L. Pan, Partner, Orrick, Herrington & Sutcliffe LLP

Panelists:

  • Ed Haug, Partner, Frommer Lawrence & Haug LLP
  • Dr. Judy Jarecki-Black, Esq., Global Head, Intellectual Property, Merial Limited
  • Loretta Smith, Senior IP Counsel, DuPont Legal
  
12:15 – 1:25 PM Lunch with the Experts  
1:30 – 2:25 PM South Korea:
A Rising Player in the Global Biopharmaceutical Industry

Moderator:

  • Do-Hyun Cho, PhD, President & CEO, W Medical Strategies

Panelists:

  • Han S. Bang, Managing Director, Betachem, inc.
  • Tae-Wan Kim, PhD, Associate Professor, Columbia University Medical School
  
2:30 – 3:45 PM

A Big Pharma View of Global Collaboration and Trans-Pacific Drug Development

Moderator:

  • Andrew Forman, Global Life Sciences, Transaction Advisory Services, EY

Panelists:

  • Yuan-Hua Ding, PhD, Executive Director & Head of External R&D Innovation – Asia/Pacific, Pfizer
  • Iain D. Dukes, MA, D.Phil, Senior Vice President, MRL Licensing and External Scientific Affairs, Merck
  • Terence G. Porter, PhD, Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals International, Inc.
  • Theodore Torphy, PhD, Senior Vice President, Research & Development, BioMotiv
  
3:45 – 4:45 PM Closing Reception